Angiogenesis Modulators Market Report

Global and Region Angiogenesis Modulators Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 31, 2022
  • PAGES：208
  • REPORT CODE：GMM950556
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Angiogenesis Modulators market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Angiogenesis Modulatorsmarket, defines the market attractiveness level of Angiogenesis Modulators market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Angiogenesis Modulators industry, describes the types of Angiogenesis Modulators market, the applications of major players and the market size, and deeply analyzes the current situation of the global Angiogenesis Modulators market and the development prospects and opportunities of Angiogenesis Modulators industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Angiogenesis Modulators market in Chapter 13.

    By Player:

    • Eisai Co Ltd (Japan)

    • Genentech Inc (USA)

    • Eli Lilly and Company (USA)

    • Amgen Inc (USA)

    • Bayer Pharma AG (Germany)

    • FHoffmann-La Roche AG (Switzerland)

    • GlaxoSmithKline plc (UK)

    • AstraZeneca plc (UK)

    • CASI Pharmaceuticals Inc (USA)

    • Celgene Corporation (USA)

    • Bionomics Ltd (Australia)

    By Type:

    • Angiogenesis Inhibitors

    • Angiogenesis Stimulators

    • Angiogenin

    • Others

    By End-User:

    • Breast Cancer

    • Colorectal Cancer

    • Lung Cancer

    • Prostate Cancer

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Angiogenesis Modulators Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Angiogenesis Modulators Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Angiogenesis Modulators Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Angiogenesis Modulators Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Angiogenesis Modulators Market Analysis and Outlook to 2022

    • 7.1 Global Angiogenesis Modulators Consumption (2017-2022)

    • 7.2 United States Angiogenesis Modulators Consumption (2017-2022)

    • 7.3 Europe Angiogenesis Modulators Consumption (2017-2022)

    • 7.4 China Angiogenesis Modulators Consumption (2017-2022)

    • 7.5 Japan Angiogenesis Modulators Consumption (2017-2022)

    • 7.6 India Angiogenesis Modulators Consumption (2017-2022)

    • 7.7 South Korea Angiogenesis Modulators Consumption (2017-2022)

    8 Region and Country-wise Angiogenesis Modulators Market Analysis and Outlook to 2028

    • 8.1 Global Angiogenesis Modulators Consumption Forecast (2022-2028)

    • 8.2 United States Angiogenesis Modulators Consumption Forecast (2022-2028)

    • 8.3 Europe Angiogenesis Modulators Consumption Forecast (2022-2028)

    • 8.4 China Angiogenesis Modulators Consumption Forecast (2022-2028)

    • 8.5 Japan Angiogenesis Modulators Consumption Forecast (2022-2028)

    • 8.6 India Angiogenesis Modulators Consumption Forecast (2022-2028)

    • 8.7 South Korea Angiogenesis Modulators Consumption Forecast (2022-2028)

    9 Global Angiogenesis Modulators Market Outlook by Types and Applications to 2022

    • 9.1 Global Angiogenesis Modulators Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Angiogenesis Inhibitors Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Angiogenesis Stimulators Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Angiogenin Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Angiogenesis Modulators Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Breast Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Colorectal Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Lung Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Prostate Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Angiogenesis Modulators Market Outlook by Types and Applications to 2028

    • 10.1 Global Angiogenesis Modulators Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Angiogenesis Inhibitors Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Angiogenesis Stimulators Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Angiogenin Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Angiogenesis Modulators Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Colorectal Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Lung Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Angiogenesis Modulators Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Angiogenesis Modulators Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Angiogenesis Modulators Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Angiogenesis Modulators Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Angiogenesis Modulators Market Competitive Analysis

    • 14.1 Eisai Co Ltd (Japan)

      • 14.1.1 Eisai Co Ltd (Japan) Company Details

      • 14.1.2 Eisai Co Ltd (Japan) Angiogenesis Modulators Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Eisai Co Ltd (Japan) Angiogenesis Modulators Product and Service

    • 14.2 Genentech Inc (USA)

      • 14.2.1 Genentech Inc (USA) Company Details

      • 14.2.2 Genentech Inc (USA) Angiogenesis Modulators Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Genentech Inc (USA) Angiogenesis Modulators Product and Service

    • 14.3 Eli Lilly and Company (USA)

      • 14.3.1 Eli Lilly and Company (USA) Company Details

      • 14.3.2 Eli Lilly and Company (USA) Angiogenesis Modulators Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Eli Lilly and Company (USA) Angiogenesis Modulators Product and Service

    • 14.4 Amgen Inc (USA)

      • 14.4.1 Amgen Inc (USA) Company Details

      • 14.4.2 Amgen Inc (USA) Angiogenesis Modulators Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Amgen Inc (USA) Angiogenesis Modulators Product and Service

    • 14.5 Bayer Pharma AG (Germany)

      • 14.5.1 Bayer Pharma AG (Germany) Company Details

      • 14.5.2 Bayer Pharma AG (Germany) Angiogenesis Modulators Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Bayer Pharma AG (Germany) Angiogenesis Modulators Product and Service

    • 14.6 FHoffmann-La Roche AG (Switzerland)

      • 14.6.1 FHoffmann-La Roche AG (Switzerland) Company Details

      • 14.6.2 FHoffmann-La Roche AG (Switzerland) Angiogenesis Modulators Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 FHoffmann-La Roche AG (Switzerland) Angiogenesis Modulators Product and Service

    • 14.7 GlaxoSmithKline plc (UK)

      • 14.7.1 GlaxoSmithKline plc (UK) Company Details

      • 14.7.2 GlaxoSmithKline plc (UK) Angiogenesis Modulators Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 GlaxoSmithKline plc (UK) Angiogenesis Modulators Product and Service

    • 14.8 AstraZeneca plc (UK)

      • 14.8.1 AstraZeneca plc (UK) Company Details

      • 14.8.2 AstraZeneca plc (UK) Angiogenesis Modulators Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 AstraZeneca plc (UK) Angiogenesis Modulators Product and Service

    • 14.9 CASI Pharmaceuticals Inc (USA)

      • 14.9.1 CASI Pharmaceuticals Inc (USA) Company Details

      • 14.9.2 CASI Pharmaceuticals Inc (USA) Angiogenesis Modulators Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 CASI Pharmaceuticals Inc (USA) Angiogenesis Modulators Product and Service

    • 14.10 Celgene Corporation (USA)

      • 14.10.1 Celgene Corporation (USA) Company Details

      • 14.10.2 Celgene Corporation (USA) Angiogenesis Modulators Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Celgene Corporation (USA) Angiogenesis Modulators Product and Service

    • 14.11 Bionomics Ltd (Australia)

      • 14.11.1 Bionomics Ltd (Australia) Company Details

      • 14.11.2 Bionomics Ltd (Australia) Angiogenesis Modulators Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Bionomics Ltd (Australia) Angiogenesis Modulators Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Angiogenesis Modulators

    • Figure Angiogenesis Modulators Picture

    • Table Global Angiogenesis Modulators Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Angiogenesis Modulators Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Angiogenesis Modulators Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Angiogenesis Modulators Consumption by Country (2017-2022)

    • Figure United States Angiogenesis Modulators Consumption and Growth Rate (2017-2022)

    • Table Europe Angiogenesis Modulators Consumption and Growth Rate (2017-2022)

    • Figure China Angiogenesis Modulators Consumption and Growth Rate (2017-2022)

    • Figure Japan Angiogenesis Modulators Consumption and Growth Rate (2017-2022)

    • Figure India Angiogenesis Modulators Consumption and Growth Rate (2017-2022)

    • Figure South Korea Angiogenesis Modulators Consumption and Growth Rate (2017-2022)

    • Figure Global Angiogenesis Modulators Consumption Forecast by Country (2022-2028)

    • Figure United States Angiogenesis Modulators Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Angiogenesis Modulators Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Angiogenesis Modulators Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Angiogenesis Modulators Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Angiogenesis Modulators Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Angiogenesis Modulators Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Angiogenesis Inhibitors Consumption and Growth Rate (2017-2022)

    • Figure Global Angiogenesis Stimulators Consumption and Growth Rate (2017-2022)

    • Figure Global Angiogenin Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Breast Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Colorectal Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Lung Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Angiogenesis Inhibitors Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Angiogenesis Stimulators Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Angiogenin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Colorectal Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Lung Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Angiogenesis Modulators Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Angiogenesis Modulators Export by Region (Top 5 Countries) (2017-2028)

    • Table Eisai Co Ltd (Japan) (Foundation Year, Company Profile and etc.)

    • Table Eisai Co Ltd (Japan) Angiogenesis Modulators Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eisai Co Ltd (Japan) Angiogenesis Modulators Product and Service

    • Table Genentech Inc (USA) (Foundation Year, Company Profile and etc.)

    • Table Genentech Inc (USA) Angiogenesis Modulators Sales, Price, Value and Gross Profit (2017-2022)

    • Table Genentech Inc (USA) Angiogenesis Modulators Product and Service

    • Table Eli Lilly and Company (USA) (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly and Company (USA) Angiogenesis Modulators Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly and Company (USA) Angiogenesis Modulators Product and Service

    • Table Amgen Inc (USA) (Foundation Year, Company Profile and etc.)

    • Table Amgen Inc (USA) Angiogenesis Modulators Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amgen Inc (USA) Angiogenesis Modulators Product and Service

    • Table Bayer Pharma AG (Germany) (Foundation Year, Company Profile and etc.)

    • Table Bayer Pharma AG (Germany) Angiogenesis Modulators Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer Pharma AG (Germany) Angiogenesis Modulators Product and Service

    • Table FHoffmann-La Roche AG (Switzerland) (Foundation Year, Company Profile and etc.)

    • Table FHoffmann-La Roche AG (Switzerland) Angiogenesis Modulators Sales, Price, Value and Gross Profit (2017-2022)

    • Table FHoffmann-La Roche AG (Switzerland) Angiogenesis Modulators Product and Service

    • Table GlaxoSmithKline plc (UK) (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline plc (UK) Angiogenesis Modulators Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline plc (UK) Angiogenesis Modulators Product and Service

    • Table AstraZeneca plc (UK) (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca plc (UK) Angiogenesis Modulators Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca plc (UK) Angiogenesis Modulators Product and Service

    • Table CASI Pharmaceuticals Inc (USA) (Foundation Year, Company Profile and etc.)

    • Table CASI Pharmaceuticals Inc (USA) Angiogenesis Modulators Sales, Price, Value and Gross Profit (2017-2022)

    • Table CASI Pharmaceuticals Inc (USA) Angiogenesis Modulators Product and Service

    • Table Celgene Corporation (USA) (Foundation Year, Company Profile and etc.)

    • Table Celgene Corporation (USA) Angiogenesis Modulators Sales, Price, Value and Gross Profit (2017-2022)

    • Table Celgene Corporation (USA) Angiogenesis Modulators Product and Service

    • Table Bionomics Ltd (Australia) (Foundation Year, Company Profile and etc.)

    • Table Bionomics Ltd (Australia) Angiogenesis Modulators Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bionomics Ltd (Australia) Angiogenesis Modulators Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US